These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20166135)

  • 1. Association of hepsin gene variants with prostate cancer risk and prognosis.
    Holt SK; Kwon EM; Lin DW; Ostrander EA; Stanford JL
    Prostate; 2010 Jun; 70(9):1012-9. PubMed ID: 20166135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.
    Kim HJ; Han JH; Chang IH; Kim W; Myung SC
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):353-8. PubMed ID: 22665141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the HEPSIN gene are associated with prostate cancer in men of European origin.
    Pal P; Xi H; Kaushal R; Sun G; Jin CH; Jin L; Suarez BK; Catalona WJ; Deka R
    Hum Genet; 2006 Sep; 120(2):187-92. PubMed ID: 16783571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
    Langeberg WJ; Tahir SA; Feng Z; Kwon EM; Ostrander EA; Thompson TC; Stanford JL
    Prostate; 2010 Jun; 70(9):1020-35. PubMed ID: 20209490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
    Holt SK; Karyadi DM; Kwon EM; Stanford JL; Nelson PS; Ostrander EA
    Clin Cancer Res; 2008 Jun; 14(12):3823-31. PubMed ID: 18559602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D pathway gene variants and prostate cancer prognosis.
    Holt SK; Kwon EM; Koopmeiners JS; Lin DW; Feng Z; Ostrander EA; Peters U; Stanford JL
    Prostate; 2010 Sep; 70(13):1448-60. PubMed ID: 20687218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D pathway gene variants and prostate cancer risk.
    Holt SK; Kwon EM; Peters U; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1929-33. PubMed ID: 19454612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer.
    Zhu Q; Meng Y; Li S; Xin J; Du M; Wang M; Cheng G
    Gene; 2022 Jan; 808():145953. PubMed ID: 34500048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
    Salinas CA; Koopmeiners JS; Kwon EM; FitzGerald L; Lin DW; Ostrander EA; Feng Z; Stanford JL
    Prostate; 2009 Mar; 69(4):363-72. PubMed ID: 19058137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
    Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
    Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
    Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.
    Kim MS; Lee HN; Kim HJ; Myung SC
    Int Braz J Urol; 2015; 41(5):869-97. PubMed ID: 26689513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP17 polymorphisms and prostate cancer outcomes.
    Wright JL; Kwon EM; Lin DW; Kolb S; Koopmeiners JS; Feng Z; Ostrander EA; Stanford JL
    Prostate; 2010 Jul; 70(10):1094-101. PubMed ID: 20503394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Established prostate cancer susceptibility variants are not associated with disease outcome.
    Wiklund FE; Adami HO; Zheng SL; Stattin P; Isaacs WB; Grönberg H; Xu J
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1659-62. PubMed ID: 19423541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
    FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
    Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
    Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
    J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.